Topics
- The U.S. FDA`s Shifting / New Emphasis
- The Globalization of the regulated Medical Products Industry
- QSIT and Q10 Focus; and Q8 and Q9 "Lessons"
- Core Expectations
- The Supply Chain
- High Risk Areas
- Pedigrees
- Ranking Schemes
- Entropy
Who should Attend
QA, Senior management in Drugs, Devices, Biologics, Dietary Supplements, R&D, RA, Production, Engineering and Operations.